MoneyWorks4Me

Bliss GVS Pharma - Quaterly Results

03 Aug 2022 Evaluate
The company witnessed a 10.71% growth in the revenue at Rs. 1472.80 millions for the quarter ended June 2022 as compared to Rs. 1330.30 millions during the year-ago period.A slim rise of 13.79% was recorded in the Net profit for the quarter ended June 2022 to Rs. 246.44  millions  From Rs. 216.58 millions.Operating Profit saw a handsome growth to 377.81 millions from 338.26 millions in the quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1472.80 1330.30 10.71 1472.80 1330.30 10.71 6363.57 4655.13 36.70
Other Income 186.34 78.95 136.02 186.34 78.95 136.02 326.28 176.83 84.52
PBIDT 377.81 338.26 11.69 377.81 338.26 11.69 1418.26 1091.43 29.95
Interest 20.42 13.00 57.08 20.42 13.00 57.08 43.24 41.94 3.10
PBDT 357.39 325.26 9.88 357.39 325.26 9.88 1402.47 1049.49 33.63
Depreciation 36.74 34.81 5.54 36.74 34.81 5.54 138.47 137.62 0.62
PBT 320.65 290.45 10.40 320.65 290.45 10.40 1264.00 911.87 38.62
TAX 74.21 73.87 0.46 74.21 73.87 0.46 337.36 236.86 42.43
Deferred Tax -12.25 9.86 -224.24 -12.25 9.86 -224.24 7.68 11.69 -34.30
PAT 246.44 216.58 13.79 246.44 216.58 13.79 926.64 675.01 37.28
Equity 103.81 103.36 0.44 103.81 103.36 0.44 103.68 103.15 0.51
PBIDTM(%) 25.65 25.43 0.89 25.65 25.43 0.89 22.29 23.45 -4.94
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..